Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record now includes an NIH funding note (2018) in the identifiers section, indicating U.S. NIH support for the trial. The page's revision line was updated to Revision: v3.6.6, replacing the older v3.6.5 tag.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:21.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing the previous v3.6.4 in the revision history. This reflects a small update to the page's metadata without altering study information.
    Difference
    0.0%
    Check dated 2026-08-08T18:25:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page. This reflects a minor revision history update without altering the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-25T11:42:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor platform update to the study page. This change reflects backend/content refresh rather than any new information about the trial itself.
    Difference
    0.0%
    Check dated 2026-07-03T22:55:33.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added to the page and the previous v3.6.0 entry was removed, updating the study record's version history. This reflects an updated page version without altering study data or content.
    Difference
    0.0%
    Check dated 2026-06-26T23:15:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added recruitment status indicating that the study is no longer recruiting participants. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) were introduced, and the revision/versioning was updated to v3.6.0 while the older heading and revision note were removed.
    Difference
    0.3%
    Check dated 2026-06-12T16:14:59.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.